New funding - OCT 2025

I am delighted to share that our group at Marseille Medical Genetics (Inserm / Aix-Marseille University) has received funding from the French Foundation for Rare Diseases as part of its 2025 specific call for projects.

This funding will support an innovative multi-omic study aimed at improving the diagnosis of patients affected by muscular dystrophies but who remain without a definitive genetic diagnosis.

Despite advances in sequencing technologies, many patients still lack a clear molecular diagnosis, limiting clinical management and therapeutic perspectives.

Our approach combines genomic, transcriptomic, and proteomic analyses to better understand disease mechanisms and identify new diagnostic markers.The project started in September 2025 and is part of the broader mission of our laboratory to bridge fundamental research and precision medicine in rare diseases.

I would like to warmly thank the French Foundation for Rare Diseases for their support, as well as all collaborators and patients involved in this collective effort.